Abstract Human exposure to mercuric species occurs regularly throughout the world. Mercuric ions may accumulate in target cells and subsequently lead to cellular intoxication and death. Therefore, it is important to have a thorough understanding of how transportable species of mercury are handled by specific membrane transporters. The purpose of the current study was to characterize the transport kinetics of cysteine (Cys)-S-conjugates of inorganic mercury (Cys-S-Hg-S-Cys) at the site of the multidrug resistance-associated transporter 2 (MRP2). In order to estimate the maximum velocity (V max ) and Michaelis constant (K m ) for the uptake of Cys-S-Hg-SCys mediated by MRP2, in vitro studies were carried out using radioactive Cys-S-Hg-S-Cys (5 μM) and inside-out membrane vesicles made from Sf9 cells transfected with MRP2. The V max was estimated to be 74.3 ± 10.1 nmol mg protein −1 30 s −1 while the K m was calculated to be 63.4 ± 27.3 μM. In addition, in vivo studies were utilized to measure the disposition of inorganic mercury (administered dose 0.5 μmol kg −1 in 2 mL normal saline) over time in Wistar and TR¯(Mrp2-deficient) rats. These studies measured the disposition of mercuric ions in the kidney, liver, and blood. In general, the data suggest that the initial uptake of mercuric conjugates into select target cells is rapid followed by a period of slower uptake and accumulation. Overall, the data indicate that MRP2 transports Cys-S-Hg-S-Cys in a manner that is similar to that of other MRP2 substrates.
Introduction
Humans may be exposed to various forms of mercury through environmental, occupational, and/or dietary sources. In general, the majority of human exposure to mercuric compounds occurs following the ingestion of fish contaminated with organic forms of mercury (e.g., methylmercury, MeHg) [1] . Individuals with diets high in fish and seafood often have blood levels of MeHg that are higher than the minimum level recommended by the EPA [2, 3] . MeHg is absorbed readily by the gastrointestinal tract of humans [4, 5] , following which it may be biotransformed to inorganic mercury (Hg 2+ ) [6] [7] [8] . The biotransformation process is fairly rapid; approximately one half of the absorbed MeHg is transformed to Hg 2+ within 14 days after exposure [9] . Considering that cells are likely exposed to various species of Hg 2+ , it is necessary to have a thorough understanding of the way in which Hg 2+ is handled by target tissues, organs, and cells.
The kidney, specifically the proximal tubule, is the primary site of uptake and accumulation of Hg 2+ [10] . Hg 2+ appears to be taken up at the luminal and basolateral membranes of proximal tubular cells as a conjugate of one or more thiolcontaining biomolecules, such as cysteine (Cys) [10] . At the luminal membrane of proximal tubular cells, the uptake of Cys-S-Hg-S-Cys has been shown to be mediated by the amino acid transporter, system b 0,+ [11] . At the basolateral membrane, organic anion transporters (OAT) 1 and 3 have been shown to play important roles in the uptake of Cys-S-Hg-SCys [12] .
Accumulation of mercuric ions within the intracellular compartment of cells may lead to oxidative stress, cellular intoxication, and eventual necrosis. Therefore, it is critical that cells possess mechanisms that can be utilized to eliminate mercuric ions. Previous studies have shown that the export of mercuric conjugates from within proximal tubular cells into the tubular lumen involves membrane transporters localized in the apical plasma membrane [13, 14] . Two of these transporters have been identified as the multidrug resistanceassociated transporter 2 (MRP2) and the breast cancer resistance protein (BCRP). Based on previous data, it appears that MRP2 is the predominant carrier involved in the proximal tubular export of mercuric conjugates. Despite the importance of this carrier in the proximal tubular export of Hg
2+
, there is little information regarding the way in which mercuric conjugates are handled at the site of MRP2. Therefore, the purpose of the current study was to define and characterize the transport of a transportable form of Hg 2+ (i.e., Cys-S-Hg-S-Cys) via MRP2.
Materials and Methods
Radioactive Mercury ) was generated according to a published method described previously [11, 15] . Briefly, 3 mg of mercuric oxide (87% enriched   202 Hg; Trace Sciences) was subjected to irradiation for 4 weeks at the University of Missouri Research Reactor (MURR). The irradiated mercuric oxide was dissolved in 1 N HCl and stored at − 20°C.
Membrane Vesicles
Inside-out membrane vesicles made from Sf9 cells containing human MRP2 (catalog number SBVT05) were purchased from Sigma-Aldrich. These vesicles are produced by Solvo Biotechnology (Budapest, Hungary) and are distributed in the USA by Sigma-Aldrich. Each lot of vesicles produced by Solvo Biotechnology is tested for transporter functionality and is certified to be suitable for studies involving the designated transporter. Our laboratory has utilized vesicles from Solvo Biotechnology previously with success [13, [16] [17] [18] . Vesicular transport assays were carried out using a rapid filtration method according to a published protocol [16, 19, 20] . Briefly, cysteine (Cys)-S-conjugates of Hg 2+ (Cys-S-Hg-SCys) were formed by mixing 5 μM radioactive mercury ([ 203 Hg]) with 12.5 μM Cys in incubation buffer (250 mM sucrose, 10 mM Tris/HCl, pH 7.4) supplemented with 10 mM MgCl 2 , 10 mM creatine phosphate, and 100 μg mL −1 creatine phosphokinase in the presence of 4 mM ATP or AMP. Incubation buffer containing Cys-S-Hg-S-Cys was added to the vesicle mixture (7.5 μg protein) and incubated for 0.25, 0. [21, 22] . These rats represent a reliable model that has been used to study the hepatic and renal secretion of various Mrp2 substrates [23] [24] [25] . All animals were provided a commercial laboratory diet (Tekland 6% rat diet, Harlan Laboratories) and water ad libitum throughout all aspects of animal experimentation. Animals were handled in accordance with the Guide for the Care and Use of Laboratory Animals as adopted by the National Institutes of Health. The animal protocol utilized in these studies was approved by the Mercer University Animal Care and Use Committee.
Intravenous Injections
Twelve Wistar (control) and 12 TR ─ rats were injected intravenously according to a previously published protocol [13, 17] . Each animal was anesthetized with isoflurane and a small incision was made in the skin in the mid-ventral region of the thigh to expose the femoral vein and artery. The fascia around the femoral vein was trimmed and a non-nephrotoxic dose of HgCl 2 (0.5 μmol kg −1 in 2 mL normal saline containing 1 μCi
of [
203 Hg] per rat) was administered into the vein. The wound was closed using two 9-mm stainless steel wound clips. Following the administration of HgCl 2 , Wistar and TR ─ rats were divided randomly into three groups, with each group consisting of four rats. Animals were placed in individual plastic metabolic cages, in which water and food were provided ad libitum. Rats were euthanized 15 min, 1 h, or 24 h after administration of HgCl 2 .
Collection of Tissues, Organs, Urine, and Feces
At the time of euthanasia, rats were anesthetized with an intraperitoneal injection of ketamine (70 mg kg
) and xylazine (30 mg kg Hg] content, while the other sample was placed in a Microtainer tube (Becton Dickenson), which was centrifuged at 21,000×g for 90 s. Subsequently, the cellular and plasma fractions were removed and placed in separate polystyrene tubes for estimation of Hg content. Total blood volume was estimated to be 6% of body weight [26] .
The right and left kidneys were also removed from each animal. Each kidney was weighed and cut in half along a transverse plain. A 3-mm transverse slice of the left kidney was utilized for separation of the cortex, outer stripe of outer medulla, and inner stripe of outer medulla and inner medulla. Each zone of the kidney was weighed and placed in a polystyrene tube for estimation of [ 
Data Analyses
Data for each experiment were analyzed first with the Kolmogorov-Smirnov test for normality and then with Levene's test for homogeneity of variances. Data were then analyzed using a two-way analysis of variance (ANOVA) to assess differences among the means. When statistically significant F-values were obtained with ANOVA, the data were analyzed using Tukey's post hoc multiple comparison test. A p value of < 0.05 was considered statistically significant.
Results

Analyses of Hg Transport in Membrane Vesicles
The viability of inside-out membrane vesicles containing hMRP2 as a system to study the activity of MRP2 was assessed by measuring the uptake of PAH in the presence and absence of 3 mM GSH (Fig. 1a) . The ATP-dependent uptake of PAH was inhibited significantly by the presence of excess GSH, which is a competitive substrate of MRP2. In addition, the uptake of Cys-S-Hg-S-Cys into hMRP2 vesicles was measured in the presence and absence of 3 mM GSH (Fig. 1b) . Like PAH, the presence of excess GSH significantly inhibited the uptake of Cys-S-Hg-S-Cys. Collectively, these data indicate that the inside-out membrane vesicles containing hMRP2, purchased from Solvo, are appropriate models of the study of MRP2-mediated transport processes.
The time-course of uptake of Cys-S-Hg-S-Cys into insideout membrane vesicles containing hMRP2 is shown in Fig. 2a . The uptake of Cys-S-Hg-S-Cys into MRP2 vesicles increased significantly over time. Uptake was linear between 15 s and 1 min; therefore, 30 s was chosen as a time point for subsequent studies. The Michaelis-Menten kinetics of Cys-SHg-S-Cys transport by MRP2 was assessed in inside-out membrane vesicles containing hMRP2 (Fig. 2b) . The V max was estimated to be 74.3 ± 10.1 nmol mg protein −1 30 s
while the K m was calculated to be 63.4 ± 27.3 μM. The Eadie-Hofstee plot (inset) shows that a single transport process is involved in this transport. In addition, the ATP-dependent transport of 10 μM Cys-S-Hg-S-Cys into inside-out membrane vesicles containing human MRP2 was measured for 30 s at 37°C in the presence or absence of GSH (b). The asterisk symbol indicates a statistical significance (p < 0.05) from the corresponding group of vesicles exposed to buffer
Analysis of the Disposition of Hg in Rat Organs
The burden of Hg +2 in the total renal mass of rats following exposure to 0.5 μmol kg −1 HgCl 2 is shown in Fig. 3 . The accumulation of Hg 2+ was greater in the kidneys of TR¯rats than in the kidneys of Wistar rats at each time measured.
When the concentration of Hg 2+ was assessed in the zones of the kidney, the cortex was found to be the primary site of accumulation of mercuric ions (Fig. 4a) . The cortical concentration of Hg 2+ was greater in TR¯rats than that in Wistar rats at each time studied. The amount of Hg 2+ also increased significantly over time. In the outer stripe of the outer medulla (OSOM), the concentration of Hg 2+ was greater in TR¯rats than that in Wistar animals following the 15-min and 1-h exposures (Fig. 4b) . The concentration of Hg 2+ in the OSOM of Wistar rats following the 24-h exposure to HgCl 2 was not significantly different from that in TR¯rats. The amount of Hg 2+ detected in the inner stripe of the outer medulla and in the inner medulla was minimal (data not shown).
The amount of Hg 2+ in the liver was also measured 15 min, 1 h, and 24 h after exposure to HgCl 2 (Fig. 5) . In Wistar rats, the hepatic burden of Hg 2+ decreased over time. The amount of Hg 2+ in the liver of Wistar rats after a 1-h exposure to HgCl 2 was significantly lower than that following a 15-min exposure. Similarly, the hepatic burden of Hg 2+ following a 24-h exposure was significantly lower than that of the 1-h and 15-min exposures. Interestingly, there was no significant difference in the hepatic burden of Hg 2+ among the three groups of TR¯rats. The hepatic burden of Hg 2+ was, however, significantly greater for TR¯rats exposed for 1 and 24 h than that in the corresponding groups of Wistar rats.
The hematologic burden of Hg 2+ (Fig. 6 ) was similar in Wistar and TR¯rats. In each strain of rats, the amount of Hg 2+ in blood was greatest after the 15-min exposure to HgCl 2 . The hematologic burden of Hg 2+ after a 1-h exposure to HgCl 2 was significantly lower than that of the 15-min exposure. Similarly, the amount of Hg 2+ in blood after a 24-h exposure was significantly lower than that observed after the 15-min and 1-h exposures. There was no significant difference in the hematologic burden of Hg 2+ between Wistar and TR¯rats at any time point.
Discussion
Understanding the transport kinetics of mercuric conjugates at the site of a specific transport protein is an important step in Fig. 3 Burden of Hg in the total renal mass. The amount of Hg in the total renal mass of Wistar and TR¯kidneys was measured 15 min, 1 h, or 24 h after exposure to 0.5 μmol kg −1 HgCl 2 . The asterisk indicates a significant difference (p < 0.05) from the mean of the corresponding group of Wistar rats. The plus sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain of rats exposed for 15 min. The number sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain exposed for 1 h Fig. 2 Time-course and saturation kinetics of MRP2-mediated transport of Cys-S-Hg-S-Cys. The transport of 5 μM radioactive Cys-S-Hg-S-Cys into inside-out membrane vesicles containing human MRP2 was measured for 15 s, 30 s, 1 min, 2.5 min, and 5 min (a). Analyses of Michaelis-Menten kinetics were also carried out in inside-out membrane vesicles containing human MRP2. Vesicles were incubated with 5 μM radioactive Cys-S-Hg-S-Cys in the presence of the buffer or 50, 100, or 500 μM unlabeled Cys-S-Hg-S-Cys (b). The maximum velocity (V max ) for the transport of Cys-S-Hg-S-Cys via MRP2 was estimated to be 74.3 ± 10.1 nmol mg protein −1 30 s −1 and the Michaelis constant (K m ) was 63.4 ± 27.3 μM understanding how mercuric ions are handled within a specific cell type and organ. There are few data characterizing the transport kinetics of any mercuric conjugate at the site of a specific transporter. Yet, a thorough understanding of the way mercuric conjugates are eliminated from the body is important in that the development of therapeutic regimes for mercury intoxication relies on data related to the transport properties of Hg
2+
. Since proximal tubular cells are the primary sites of Hg 2+ accumulation and intoxication, and because they appear to play a major role in the excretion of Hg 2+ , the current study was designed to characterize the export of mercuric ions from within proximal tubular cells. Furthermore, since MRP2 has been shown to play an important role in the export of mercuric conjugates from within proximal tubular cells [13, 16, 17] , this study focused on characterizing the transport of Hg 2+ at the site of MRP2.
Following Hg
2+ intoxication, 2,3-dimercapto-1-propanesulfonatic acid (DMPS) may be administered to patients as a means to extract mercuric ions from within target cells [27] . DMPS-S-conjugates of Hg 2+ have been shown to be transported readily by MRP2 [13, 17] but the formation of these conjugates is dependent upon intravenous administration of DMPS by a physician and subsequent uptake of DMPS into affected cells. In the current study, we chose to focus on the transport of a species of Hg 2+ that may form in the initial moments after exposure to mercuric compounds (e.g., Cys-S-Hg-S-Cys). Since Cys-S-Hg-S-Cys may be formed in blood and target cells immediately after exposure to Hg 2+ [28] , this study mimics conditions immediately The asterisk indicates a significant difference (p < 0.05) from the mean of the corresponding group of Wistar rats. The plus sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain of rats exposed for 15 min. The number sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain exposed for 1 h The plus sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain of rats exposed for 15 min. The number sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain exposed for 1 h Fig. 6 Amount of Hg in blood. The amount of Hg in the total blood of Wistar and TR¯kidneys was measured 15 min, 1 h, or 24 h after exposure to 0.5 μmol kg −1 HgCl 2 . The asterisk indicates a significant difference (p < 0.05) from the mean of the corresponding group of Wistar rats. The plus sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain of rats exposed for 15 min. The number sign indicates a significant difference (p < 0.05) from the mean of the group of rats of the same strain exposed for 1 h following exposure Hg 2+ (but prior to administration of a chelator compound) [18] .
Time-course studies using inside-out membrane vesicles containing human MRP2 indicate that MRP2-mediated transport of Cys-S-Hg-S-Cys is linear and rapid up to 1 min, at which point, accumulation within the vesicles begins to decline. Based on this finding, we suggest that the most rapid transport of Cys-S-Hg-S-Cys by MRP2 may occur in the initial moments after this mercuric conjugate is taken up into proximal tubular cells. Michaelis-Menten transport kinetics were assessed for Cys-S-Hg-S-Cys at the site of MRP2 and a K m of 63.4 ± 27.3 μM was calculated. MPR2 has been shown to transport numerous substrates with a variety of different affinities. Leukotriene C 4 is considered to be a high affinity substrate of MRP2 with a K m of 250 nM [29] while the K m for glutathione disulfide (GSSG), which is also considered to be an excellent substrate of MRP2, has been shown to be 93 ± 26 μM [30] . The K m for Cys-S-Hg-S-Cys is similar to that of two well-known substrates of MRP2, β-estradiol 17-(β-D-glucuronide) (E 2 17G; 75 ± 7.0 μM) and β-estradiol 3-(β-D-glucuronide) (E 2 3G; 122 ± 23 μM) [31] . Since the K m values of E 2 17G and E 2 3G are similar to that of Cys-S-Hg-SCys, we propose that Cys-S-Hg-S-Cys is transported by MRP2 in a way similar to that of E 2 17G and E 2 3G. Considering that E 2 17G and E 2 3G are often utilized as model substrates that are transported readily by MRP2, we suggest that Cys-S-Hg-S-Cys may also be transported readily by this carrier. Recently, the MRP2-mediated transport of oxaliplatin, a platinum-based chemotherapeutic agent, was characterized in MRP2-containing vesicles. The K m of oxaliplatin was calculated to be 301 μM [32] , which is significantly higher than that calculated for Cys-S-Hg-S-Cys. This finding provides some perspective on the transportability of Cys-S-Hg-S-Cys by MRP2 in that the affinity of MRP2 for Cys-S-Hg-S-Cys appears to fall in the middle of the range of substrate affinities exhibited by MRP2.
In vivo studies were utilized to assess the transport of Hg 2+ in various organs of Wistar and TR¯rats exposed to a nonnephrotoxic dose of HgCl 2 for 15 min, 1 h, or 24 h. Following exposure, the disposition of Hg 2+ was assessed in the kidneys, liver, and blood. The findings from these studies suggest that the initial uptake of mercuric ions into proximal tubular cells is rapid. In the absence of Mrp2, the amount of Hg 2+ taken up after 15 min was approximately one half of the amount of Hg 2+ that accumulated after 1 h and about one third of the total Hg 2+ that accumulated after 24 h. These findings suggest that the most rapid period of Hg 2+ uptake into target cells is in the initial minutes after exposure. Interestingly, the amount of Hg 2+ in the cortex of TR¯rats after 15 min of exposure was 3.2 times greater than that of corresponding Wistar rats. In contrast, after 1 and 24 h of exposure, the amount of Hg 2+ in the cortex of TR¯rats was only 1.3 and 1.4 times greater, respectively, than that of corresponding Wistar rats.
These data suggest that the ability of Mrp2 to remove mercuric ions from proximal tubular cells is the greatest during the initial period of exposure. It is important to note that the breast cancer resistance protein (BCRP) has also been shown to mediate the proximal tubular export of Hg 2+ [14] and thus, it may also play an important, albeit more minor, role in the export of mercuric ions in both Wistar and TR¯rats. It should also be considered that P-glycoprotein (multidrug-resistance protein, MDR1; ABCB1) has also been localized in the apical membrane of proximal tubular cells [33] and although it has not been shown to mediate the transport of mercuric ions, it may indeed play a role in this process. The protein levels of Bcrp and MDR1 have been shown to be similar in Wistar and TR¯rats [34] ; therefore, we conclude that differences in the accumulation of mercuric ions between these two strains of rats are not due to alterations in the ability of these proteins to transport mercuric ions.
The pattern of Hg 2+ accumulation in the OSOM was similar to that in the cortex. Following 15 min and 1 h of exposure to Hg 2+ , the amount of Hg 2+ in the OSOM was greater in TRr ats than that in Wistar rats. Like in the cortex, it appears that Mrp2 may play a role in the initial export of mercuric ions from proximal tubules in the OSOM. Interestingly, the accumulation of Hg 2+ after 24 h of exposure was similar in Wistar and TR¯rats. This finding is similar to that of previous studies that measured 24-h exposure of Wistar and TR¯rats to Hg 2+ [13, 18] . One possible explanation for this finding may relate to the distribution of Mrp2 in the kidney. The amount of Mrp2 protein has been shown to be lower in the OSOM than in the cortex [35] suggesting that Mrp2 may play less of a role in the export of mercuric ions from within proximal tubules located in the OSOM than in those located in the cortex. Interestingly, protein levels of Bcrp appear to be greater in the OSOM than in the cortex [14] and thus Bcrp may play a more significant role in the export of mercuric species from tubules in the OSOM, which may account for the lack of difference in the accumulation of Hg 2+ after 24 h between Wistar and TR¯rats.
When rats were exposed to HgCl 2 for 1 or 24 h, the hepatic burden of Hg 2+ was significantly greater in TR¯rats than in that of Wistar rats. This pattern of accumulation suggests that hepatobiliary excretion may account for the decrease in hepatic accumulation of Hg 2+ in Wistar rats, while in TR¯rats the absence of Mrp2 prevents a large fraction of Hg 2+ from being exported at the canalicular membrane and consequently leads to accumulation of Hg 2+ in hepatocytes. Interestingly, the hepatic burden of Hg 2+ was not significantly different between Wistar and TR¯rats after 15 min of exposure. A possible explanation for this observation is that the accumulation of Hg 2+ within hepatocytes must meet a minimum capacity before hepatobiliary export begins to occur. Under these circumstances, export of mercuric ions may not occur or may be minimal during the initial minutes after exposure. This pattern of accumulation could lead to similar levels of Hg 2+ in hepatocytes of Wistar and TR¯rats.
The amount of Hg 2+ in blood of Wistar and TR¯rats decreased significantly over time with less than 5% of the administered dose remaining in the blood after 24 h. The decrease in hematologic content of Hg 2+ may be due to accumulation in target cells of organs and/or urinary and fecal excretion. Glomerular filtration and exposure of the basolateral plasma membrane of proximal tubular cells to mercuric species may lead to luminal and basolateral absorption, respectively, by proximal tubular cells. Mercuric ions may be retained in proximal tubular cells or excreted subsequently in urine. In addition, Hg 2+ in the blood is delivered to the liver where it can be taken by hepatocytes and eliminated subsequently in feces.
In summary, the current data suggest that MRP2 transports Cys-S-conjugates of Hg 2+ in a manner similar to that of other substrates for which it has a moderate affinity. Furthermore, MRP2 serves as an important mechanism for the export of mercuric species out of renal tubular cells and hepatocytes. A thorough understanding of the way in which MRP2 mediates that transport of specific species of Hg 2+ will serve as the foundation for the development of effective therapies for extraction of mercuric ions from target cells. 
